C-Prio is honored and excited to announce that one of our founders will be speaking at LSDB’s International Awards and Conference 2024! Are you seeking the best AI solutions and strategies for SMEs? Don’t miss this online talk: “AI Model for SMEs: Axiomatic Process Tree Theory (APTT).” This innovative approach has been successfully developed into rAI-colon, a highly efficient and accurate AI cancer diagnosis model for the NHS. LIAC 2024 is a 3-day event featuring expert speakers from around the world and attendees from 35+ countries. We look forward to connecting and networking with fellow entrepreneurs. We invite our network to join this online event and enjoy all the benefits it offers. Register for free and secure your spot as an attendee. See all details here: LIAC 2024 LSDB, Shaobin Wu, Kenneth Ko, Yubing Zhu, Yuying Zhu, 張彦国, Jeremy Buitenhuis
C-Prio Ltd
Health and Human Services
We focus on developing and implementing AI tools for cancer diagnosis to help reducing NHS backlog in histopathology.
About us
C-Prio is a startup pioneering an advanced AI tool for cancer diagnosis and drug discovery, offering unparalleled training efficiency and accuracy in the field, with ability to reason, to alert for unknown and borderline features, to speed up histopathology reporting workflow by more than 66%.
- Website
-
www.c-prio.com
External link for C-Prio Ltd
- Industry
- Health and Human Services
- Company size
- 2-10 employees
- Type
- Privately Held
- Founded
- 2022
- Specialties
- AI histopathology cancer diagnosis tool, AI histopathology personalised medicine tool, and Ai histopathology cancer related drug discovery tool